B A Conley, R E Gore-Langton, B D Cheson. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/secondaryCarcinoma, Squamous Cell/therapyCetuximabClinical Trials as TopicCombined Modality TherapyHead and Neck Neoplasms/drug therapyHead and Neck Neoplasms/pathologyHead and Neck Neoplasms/therapyHumansIndoles/therapeutic usePlatinum Compounds/therapeutic usePyrroles/therapeutic useRecurrence
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsIndolesPlatinum CompoundsPyrrolesSemaxinibCetuximab
Year: 2000 PMID： 10826315
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990